NEW YORK (GenomeWeb News) – Geneart today reported that its sales for the first half of 2009 increased 3 percent to €8.1 million ($11.6 million) from €7.9 million for the first half of 2008.

The Regensburg, Germany-based gene synthesis firm said that its EBITDA for the first half was €800,000 versus €1.4 million for the comparable period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.